High-dose topotecan (90 and 180 μG) for recurrent subretinal and vitreous seeding in retinoblastoma
Purpose: To report on the use of intravitreal high-dose topotecan (90 and 180 μG) for recurrent subretinal and vitreous retinoblastoma, the toxicity of these injections, and the use of a 180-μG injection of intravitreal topotecan in humans. Observations: High-dose (90 and 180 μG) intravitreal topote...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2025-12-01
|
| Serie: | American Journal of Ophthalmology Case Reports |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2451993625001902 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
